Possible adverse reactions when using Cassimerson

Casimersen, as an innovative treatment drug for Duchenne muscular dystrophy (DMD), brings hope to patients with specific DMD gene mutations. Gene mutations in such patients allow treatment by skipping exon 45, and Kasimerson did so by altering the expression of dystrophin (dystrophin )dystrophin span>mRNAThe splicing process produces a dystrophin protein that is smaller than the normal protein but retains most of its functional domains, thus improving the symptoms of DMD patients to a certain extent.

Although Casimerson has shown positive results in the treatment ofDMD, patients also need to be aware of possible adverse reactions during use. These adverse reactions include, but are not limited to, upper respiratory tract infection, cough, fever, headache, joint pain and oropharyngeal pain. These side effects occurred at higher rates in clinical trials and are common problems patients may experience while receiving Casimerson treatment.

In addition to the common side effects mentioned above, Casimerson, as an intravenous infusion drug, may also cause infusion-related side effects, such as phlebitis, allergic reactions, etc. Anaphylaxis may manifest as rash, hives, difficulty breathing, decreased blood pressure and other symptoms, and may even be life-threatening in severe cases. Therefore, before using Casimerson, doctors will conduct a thorough patient evaluation to ensure that the patient has no history of allergies and closely monitor the patient's vital signs during the infusion.

For adverse reactions caused by Casimerson, doctors will take appropriate treatment measures based on the patient's specific situation. For common side effects, such as upper respiratory tract infection, cough, etc., doctors may advise patients to rest more, drink more water, and provide symptomatic treatment if necessary. For more serious side effects, such as allergic reactions, doctors will immediately stop the infusion and take emergency treatment measures, such as using anti-allergic drugs and maintaining a clear respiratory tract.

In short, although Casimerson is of great significance in the treatment ofDMD, patients also need to fully understand the possible adverse reactions during use and use the drug rationally under the guidance of a doctor to ensure the safety and effectiveness of the treatment.

Reference link:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213026s005lbl.pdf